J. Moitra, et.al., Life without white fat: a transgenic mouse., Genes & development, 1998, 12

http://rdf.ncbi.nlm.nih.gov/pubmed/9784492

J. Moitra, et.al., Life without white fat: a transgenic mouse., Genes & development, 1998, 12

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Tg(AZIP/F)1Vsn
  http://metadb.riken.jp/db/mgi_rdf/MGI:3497939

class

http://purl.org/net/cito/citesAsAuthority

• Tg(AZIP/F)1Vsn
  http://metadb.riken.jp/db/mgi_rdf/MGI:3497939

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased circulating triglyceride level_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0001552IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• pancreatic islet hyperplasia_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0005491IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• abnormal lipid homeostasis_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0002118IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• hepatic steatosis_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0002628IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• abnormal glucose homeostasis_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0002078IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• decreased white adipose tissue amount_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0001783IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• postnatal lethality_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0002082IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• premature death_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0002083IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• hyperglycemia_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0001559IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• weight loss_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0001263IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• increased liver weight_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0002981IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• increased body weight_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0001260IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• polyuria_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0001762IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• postnatal growth retardation_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0001732IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• reduced female fertility_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0001923IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• increased sensitivity to xenobiotic induced morbidity/mortality_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0009766IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• decreased brown adipose tissue amount_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0001780IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• increased circulating free fatty acid level_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0001554IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• increased circulating insulin level_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0002079IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• polydipsia_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0001426IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• decreased circulating leptin level_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0005668IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• abnormal lung morphology_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0001175IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• increased liver triglyceride level_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0009355IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn
• reduced male fertility_Tg(AZIP/F)1Vsn/0
  http://metadb.riken.jp/0001922IFVBNTgAZIPF1Vsn0TgAZIPF1Vsn